Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 120,623 shares at $22.50 ($2.7M) on 2019-07-18, disclosed to the SEC on 2019-07-22.
Open-market sale of $2.7M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 208 | $5K | 0.2% |
| 2 | $22.50 | 142 | $3K | 0.1% |
| 3 | $22.50 | 403 | $9K | 0.3% |
| 4 | $22.50 | 403 | $9K | 0.3% |
| 5 | $22.50 | 20,656 | $465K | 17.1% |
| 6 | $22.50 | 142 |
| $3K |
| 0.1% |
| 7 | $22.50 | 208 | $5K | 0.2% |
| 8 | $22.50 | 20 | $450 | 0.0% |
| 9 | $22.50 | 7 | $158 | 0.0% |
| 10 | $22.50 | 10 | $225 | 0.0% |
| 11 | $22.50 | 1,016 | $23K | 0.8% |
| 12 | $22.52 | 323 | $7K | 0.3% |
| 13 | $22.52 | 472 | $11K | 0.4% |
| 14 | $22.52 | 917 | $21K | 0.8% |
| 15 | $22.52 | 46,992 | $1.1M | 39.0% |
| 16 | $22.52 | 472 | $11K | 0.4% |
| 17 | $22.52 | 46,992 | $1.1M | 39.0% |
| 18 | $22.52 | 917 | $21K | 0.8% |
| 19 | $22.52 | 323 | $7K | 0.3% |
| Total | $22.52 avg | 120,623 | $2.7M | 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |